Westside Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-850
Closed -$35.5K 702
2020
Q1
$35.5K Buy
+850
New +$160K 0.02% 94
2019
Q2
$43.7K Buy
+4,257
New +$589K 0.1% 43
2018
Q4
$653K Buy
4,844
+110
+2% +$18K 0.24% 74
2018
Q3
$909K Sell
4,734
-25
-0.5% -$4.59K 0.29% 56
2018
Q2
$798K Buy
4,759
+184
+4% +$29.5K 0.28% 59
2018
Q1
$742K Buy
4,575
+1,245
+37% +$209K 0.41% 59
2017
Q4
$568K Sell
3,330
-390
-10% -$70K 0.31% 71
2017
Q3
$755K Hold
3,720
0.46% 53
2017
Q2
$897K Sell
3,720
-170
-4% -$39.9K 0.59% 43
2017
Q1
$925K Buy
3,890
+1,190
+44% +$277K 0.44% 37
2016
Q4
$583K Buy
+2,700
New +$559K 0.4% 33

Other funds holding AGN

Westside Investment Management's AGN Position: Q2 2020 in Review

Westside Investment Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 850 shares — an estimated $35.5K sold.

Westside Investment Management first reported a position in AGN in Q4 2016 and held it in 11 quarters. The position peaked at $925K in Q1 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Westside Investment Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Westside Investment Management sold 850 Allergan plc shares in Q2 2020, an estimated $35.5K.
  • Westside Investment Management first reported a position in Allergan plc in Q4 2016 and held it in 11 quarters.
  • Westside Investment Management's Allergan plc position peaked at $925K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Westside Investment Management's 13F filing for Q2 2020, filed 21 Jul 2020.